Oddity Tech .(ODD) - 2025 Q1 - Earnings Call Transcript

Financial Data and Key Metrics Changes - In Q1 2025, the company reported revenue growth of 27% to $268 million, with adjusted EBITDA of$ 52 million, representing a 19.5% adjusted EBITDA margin and free cash flow of $87 million [4][22][23] - The company expects full-year revenue growth to be between 22% and 23%, or between$ 790 million and $798 million, raising its gross margin outlook to 71% for the full year [28][29] Business Line Data and Key Metrics Changes - The growth in net revenue was primarily driven by increased orders and a 4% year-over-year increase in average order value, influenced by a mix of higher-priced products [23][25] - The company continues to expect order growth to be the primary driver of revenue growth moving forward [24] Market Data and Key Metrics Changes - International markets contributed to growth, although they currently represent less than 20% of the business, with both U.S. and international markets growing in double digits in Q1 [34][60] - The company is focusing on scaling existing markets and testing new markets, with positive results from recent tests in large developing markets [61] Company Strategy and Development Direction - The company aims to build one of the largest beauty companies globally by focusing on online consumer shifts and high-efficacy products [5][6] - Strategic priorities include driving existing brands, accelerating international expansion, and investing in new brand launches and technology [9][10][18] Management's Comments on Operating Environment and Future Outlook - Management views the current environment as a significant opportunity, emphasizing the resilience of the beauty industry and the company's strong performance [20][21] - The company remains confident in its ability to exceed long-term growth targets of 20% revenue growth and 20% adjusted EBITDA margins despite potential tariff impacts [29] Other Important Information - The company has a strong balance sheet with$ 257 million in cash equivalents and investments, zero debt, and a new undrawn $200 million credit line [26][27] - The company is actively looking for acquisition opportunities that align with its strategic goals, particularly in technology and brands that complement its existing portfolio [62] Q&A Session Summary Question: Contribution of international markets to the quarter - Management confirmed that international markets are a core part of the growth strategy, with both U.S. and international markets growing double digits in Q1, although international is still less than 20% of the business [34][60] Question: Impact of the FTC's click-to-cancel rule - Management does not foresee significant impact from the regulation, as the company has already adapted its subscription and cancellation processes to be user-friendly and self-serve [36][37] Question: Factors driving gross margin increases - Management highlighted that gross margin improvements are due to cost efficiencies and product mix, with a focus on contribution margin rather than gross margin as a key performance indicator [42][45] Question: Updates on Brand three and telehealth infrastructure - Management expressed excitement about Brand three, emphasizing the extensive testing and infrastructure built to support its launch, which is expected to address significant consumer needs [51][73] Question: Strategic focus for acquisitions - Management indicated a focus on acquiring brands with strong products or capabilities that would take significant time to develop internally, particularly in biotech and AI [62]